1.3Impact Factor
Indexed inScopus
28 daysTime to First Decision

Reproductive Medicine, Volume 2, Issue 1

March 2021 - 7 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

Select all

Article

2 Citations

4,139 Views

11 Pages

Biosensor for Detecting Fetal Growth Restriction in a Low-Resource Setting

Anders Jacobsen,
Christentze Schmiegelow,
Bjarke Sørensen,
Omari A. Msemo,
Karsten Nielsen,
Birgitte Bruun Nielsen,
Sofie Lykke Møller,
John P. A. Lusingu,
Daniel T. R. Minja and
Morten Hedegaard
+ 1 author

Reprod. Med.2021, 2(1), 57-67;https://doi.org/10.3390/reprodmed2010007

15 March 2021

One strategy for improving detection of fetal growth restriction (FGR) is developing biosensors identifying placental dysfunction as a leading pathogenesis for FGR. The aim of this pilot study was to investigate the performance of a biosensor specifi...

Full Article

Article

6 Citations

4,752 Views

7 Pages

Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction

Daniele Farsetti,
Francesca Pometti,
Grazia Maria Tiralongo,
Damiano Lo Presti,
Ilaria Pisani,
Giulia Gagliardi,
Barbara Vasapollo,
Gian Paolo Novelli and
Herbert Valensise

Reprod. Med.2021, 2(1), 50-56;https://doi.org/10.3390/reprodmed2010006

9 March 2021

Objectives: To assess umbilical vein (UV) blood flow in fetal growth restriction (FGR) and in pregnancy with small for gestational age (SGA) fetus. To evaluate the predictive capacity of UV blood flow (QUV) in the discrimination of SGA fetuses from F...

Full Article

Article

5 Citations

5,291 Views

15 Pages

Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis

Adi Sharabi-Nov,
Tanja Premru Sršen,
Kristina Kumer,
Vesna Fabjan Vodušek,
Teja Fabjan,
Nataša Tul,
Hamutal Meiri,
Kypros H. Nicolaides and
Joško Osredkar

Reprod. Med.2021, 2(1), 35-49;https://doi.org/10.3390/reprodmed2010005

1 March 2021

Objective: We previously provided evidence to confirm that maternal serum levels of soluble Fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), and their ratio are useful tools to direct the management of preeclampsia (PE), fetal gro...

Full Article

Review

6 Citations

5,526 Views

9 Pages

The Technological Advances in Embryo Selection and Genetic Testing: A Look Back at the Evolution of Aneuploidy Screening and the Prospects of Non-Invasive PGT

Channing Burks,
Kristin Van Heertum and
Rachel Weinerman

Reprod. Med.2021, 2(1), 26-34;https://doi.org/10.3390/reprodmed2010004

10 February 2021

Since the birth of the first IVF baby, Louise Brown, in 1978, researchers and clinicians have sought ways to improve pregnancy outcomes through embryo selection. In the 1990s, blastomere biopsy and fluorescence in situ hybridization (FISH) were devel...

Full Article

Article

3 Citations

4,099 Views

14 Pages

Pro- and Anti-Angiogenic Markers as Clinical Tools for Suspected Preeclampsia with and without FGR near Delivery—A Secondary Analysis

Kristina Kumer,
Adi Sharabi-Nov,
Vesna Fabjan Vodušek,
Tanja Premru Sršen,
Nataša Tul,
Teja Fabjan,
Hamutal Meiri,
Kypros Herodotos Nicolaides and
Joško Osredkar

Reprod. Med.2021, 2(1), 12-25;https://doi.org/10.3390/reprodmed2010003

8 February 2021

Objective—the objective of this study was to assess the accuracy of placental growth factor (PlGF), soluble Fms-like Tyrosine Kinase 1 (sFlt-1), and endoglin (sEng) in the diagnosis of suspected preeclampsia (PE) with and without fetal growth restric...

Full Article

Article

1 Citations

5,500 Views

10 Pages

Is the Cerebro-Placental Ratio Sufficient to Predict Adverse Neonatal Outcome in Small for Gestational Age Fetuses > 34 Weeks of Gestation?

Jarmila A. Zdanowicz,
Muriel Disler,
Roland Gerull,
Luigi Raio and
Daniel Surbek

Reprod. Med.2021, 2(1), 2-11;https://doi.org/10.3390/reprodmed2010002

2 February 2021

Fetuses with an estimated weight (EFW) below the 10th percentile are at risk for adverse perinatal outcome and clinical management remains a challenge. We examined EFW and cerebro-placental ratio (CPR) with regard to their predictive capability in th...

Full Article

Editorial

2,506 Views

1 Page

Acknowledgment to Reviewers of Reproductive Medicine in 2020

Reprod. Med. Editorial Office

Reprod. Med.2021, 2(1), 1;https://doi.org/10.3390/reprodmed2010001

28 January 2021

Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Reproductive Medicine maintains its standards for the high quality of its published papers [...]

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Reprod. Med. - ISSN 2673-3897

Imprint

Download Flyer